|Articles|January 10, 2023
Phastar Acquires S-Cubed ApS
Deal takes the Phastar group to around 550 people worldwide and strengthens the company's position in Nordic region.
Advertisement
Phastar announced the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Read more about the acquistion
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Is Artificial Intelligence Coming for Clinical Research?
2
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
